US Stock MarketDetailed Quotes

Syra Health (SYRA)

Watchlist
  • 0.5398
  • +0.0398+7.96%
15min DelayClose May 15 15:35 ET
6.44MMarket Cap-26.99P/E (TTM)

Syra Health (SYRA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
760.73%1.36M
84.73%-447.75K
-34.68%-289.19K
40.89%-244.31K
95.18%-72.48K
119.76%158.23K
-6.27%-2.93M
87.78%-214.72K
-11.93%-413.3K
-155.79%-1.5M
Net income from continuing operations
151.03%240.98K
76.16%-896.33K
73.32%-134.57K
45.90%-225.9K
95.43%-63.6K
67.36%-472.27K
-27.94%-3.76M
49.32%-504.4K
-17.82%-417.54K
-73.18%-1.39M
Depreciation and amortization
-84.49%1.05K
-67.38%20.47K
-68.44%2.3K
-78.87%5.4K
-65.59%5.98K
-45.82%6.8K
28.64%62.74K
-41.11%7.28K
106.69%25.54K
41.33%17.37K
Other non cash items
----
-98.39%2.59K
--0
--0
--0
-94.85%2.59K
32.86%160.88K
-25.53%23.03K
21.03%36.9K
68.71%50.7K
Change In working capital
86.44%1.1M
-39.87%326.98K
-179.05%-180.28K
22.81%-44.93K
81.59%-35.98K
3.30%588.17K
2,422.28%543.79K
127.67%228.05K
1.03%-58.2K
-220.93%-195.43K
-Change in receivables
118.58%49.24K
-155.19%-237.55K
-96.13%7.88K
7.09%-39.89K
534.30%59.5K
-193.50%-265.03K
490.72%430.42K
182.61%203.62K
93.31%-42.94K
76.10%-13.7K
-Change in payables and accrued expense
19.16%244.07K
159.64%182.27K
0.40%-165.53K
98.72%-1.94K
149.81%144.92K
-32.47%204.82K
-6,569.71%-305.63K
69.75%-166.2K
-134.70%-151.79K
-339.58%-290.93K
-Change in other current assets
-72.38%85.69K
-0.80%487.93K
-42.63%118.42K
-147.98%-65.5K
-11.49%124.82K
3,826.51%310.19K
142.18%491.88K
43.22%206.43K
296.13%136.53K
10.58%141.03K
-Change in other current liabilities
93.31%-16.34K
-18.07%-105.67K
38.98%-16.05K
--187.41K
-2.46%-32.61K
-679.07%-244.42K
26.09%-89.5K
14.96%-26.3K
--0
-5.90%-31.83K
-Change in other working capital
25.97%733.91K
----
----
---125K
---332.6K
9,438.34%582.6K
--16.61K
--10.5K
--0
--0
Cash from discontinued investing activities
Operating cash flow
760.73%1.36M
84.73%-447.75K
-34.68%-289.19K
40.89%-244.31K
95.18%-72.48K
119.76%158.23K
-6.27%-2.93M
87.78%-214.72K
-11.93%-413.3K
-155.79%-1.5M
Investing cash flow
Cash flow from continuing investing activities
0
99.04%-107
-107
0
0
0
27.15%-11.11K
0
0
1.79%-5.49K
Net PPE purchase and sale
--0
99.04%-107
---107
--0
--0
--0
27.15%-11.11K
--0
--0
1.79%-5.49K
Cash from discontinued investing activities
Investing cash flow
--0
99.04%-107
---107
--0
--0
--0
27.15%-11.11K
--0
--0
1.79%-5.49K
Financing cash flow
Cash flow from continuing financing activities
13.78%-54.36K
-116.17%-332.82K
16.97%-72.51K
-105.61%-85.07K
16.81%-112.18K
-108.25%-63.05K
-65.98%2.06M
-101.74%-87.33K
332.24%1.52M
-504.57%-134.85K
Net issuance payments of debt
30.17%-54.36K
15.35%-347.62K
16.97%-72.51K
17.10%-85.07K
16.81%-112.18K
9.35%-77.85K
-179.17%-410.68K
82.02%-87.33K
---102.61K
-166.90%-134.85K
Net common stock issuance
----
-99.40%14.8K
----
----
----
----
-53.69%2.47M
--0
----
----
Proceeds from stock option exercised by employees
--0
----
----
--0
--0
-98.26%14.8K
----
----
--1.62M
--0
Cash from discontinued financing activities
Financing cash flow
13.78%-54.36K
-116.17%-332.82K
16.97%-72.51K
-105.61%-85.07K
16.81%-112.18K
-108.25%-63.05K
-65.98%2.06M
-101.74%-87.33K
332.24%1.52M
-504.57%-134.85K
Net cash flow
Beginning cash position
-32.59%1.61M
-26.97%2.4M
-26.73%1.98M
44.63%2.31M
-23.08%2.49M
-26.97%2.4M
97,988.37%3.28M
14,877.56%2.7M
4,274.20%1.59M
442.91%3.24M
Current changes in cash
1,273.80%1.31M
11.76%-780.67K
-19.78%-361.81K
-129.86%-329.38K
88.76%-184.66K
325.98%95.18K
-127.00%-884.67K
-109.26%-302.05K
6,082.47%1.1M
-193.52%-1.64M
End cash Position
17.33%2.92M
-32.59%1.61M
-32.59%1.61M
-26.73%1.98M
44.63%2.31M
-23.08%2.49M
-26.97%2.4M
-26.97%2.4M
14,877.56%2.7M
4,274.20%1.59M
Free cash flow
760.73%1.36M
84.78%-447.85K
-34.73%-289.3K
40.89%-244.31K
95.20%-72.48K
119.62%158.23K
-6.09%-2.94M
87.78%-214.72K
-11.93%-413.3K
-154.30%-1.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 760.73%1.36M84.73%-447.75K-34.68%-289.19K40.89%-244.31K95.18%-72.48K119.76%158.23K-6.27%-2.93M87.78%-214.72K-11.93%-413.3K-155.79%-1.5M
Net income from continuing operations 151.03%240.98K76.16%-896.33K73.32%-134.57K45.90%-225.9K95.43%-63.6K67.36%-472.27K-27.94%-3.76M49.32%-504.4K-17.82%-417.54K-73.18%-1.39M
Depreciation and amortization -84.49%1.05K-67.38%20.47K-68.44%2.3K-78.87%5.4K-65.59%5.98K-45.82%6.8K28.64%62.74K-41.11%7.28K106.69%25.54K41.33%17.37K
Other non cash items -----98.39%2.59K--0--0--0-94.85%2.59K32.86%160.88K-25.53%23.03K21.03%36.9K68.71%50.7K
Change In working capital 86.44%1.1M-39.87%326.98K-179.05%-180.28K22.81%-44.93K81.59%-35.98K3.30%588.17K2,422.28%543.79K127.67%228.05K1.03%-58.2K-220.93%-195.43K
-Change in receivables 118.58%49.24K-155.19%-237.55K-96.13%7.88K7.09%-39.89K534.30%59.5K-193.50%-265.03K490.72%430.42K182.61%203.62K93.31%-42.94K76.10%-13.7K
-Change in payables and accrued expense 19.16%244.07K159.64%182.27K0.40%-165.53K98.72%-1.94K149.81%144.92K-32.47%204.82K-6,569.71%-305.63K69.75%-166.2K-134.70%-151.79K-339.58%-290.93K
-Change in other current assets -72.38%85.69K-0.80%487.93K-42.63%118.42K-147.98%-65.5K-11.49%124.82K3,826.51%310.19K142.18%491.88K43.22%206.43K296.13%136.53K10.58%141.03K
-Change in other current liabilities 93.31%-16.34K-18.07%-105.67K38.98%-16.05K--187.41K-2.46%-32.61K-679.07%-244.42K26.09%-89.5K14.96%-26.3K--0-5.90%-31.83K
-Change in other working capital 25.97%733.91K-----------125K---332.6K9,438.34%582.6K--16.61K--10.5K--0--0
Cash from discontinued investing activities
Operating cash flow 760.73%1.36M84.73%-447.75K-34.68%-289.19K40.89%-244.31K95.18%-72.48K119.76%158.23K-6.27%-2.93M87.78%-214.72K-11.93%-413.3K-155.79%-1.5M
Investing cash flow
Cash flow from continuing investing activities 099.04%-107-10700027.15%-11.11K001.79%-5.49K
Net PPE purchase and sale --099.04%-107---107--0--0--027.15%-11.11K--0--01.79%-5.49K
Cash from discontinued investing activities
Investing cash flow --099.04%-107---107--0--0--027.15%-11.11K--0--01.79%-5.49K
Financing cash flow
Cash flow from continuing financing activities 13.78%-54.36K-116.17%-332.82K16.97%-72.51K-105.61%-85.07K16.81%-112.18K-108.25%-63.05K-65.98%2.06M-101.74%-87.33K332.24%1.52M-504.57%-134.85K
Net issuance payments of debt 30.17%-54.36K15.35%-347.62K16.97%-72.51K17.10%-85.07K16.81%-112.18K9.35%-77.85K-179.17%-410.68K82.02%-87.33K---102.61K-166.90%-134.85K
Net common stock issuance -----99.40%14.8K-----------------53.69%2.47M--0--------
Proceeds from stock option exercised by employees --0----------0--0-98.26%14.8K----------1.62M--0
Cash from discontinued financing activities
Financing cash flow 13.78%-54.36K-116.17%-332.82K16.97%-72.51K-105.61%-85.07K16.81%-112.18K-108.25%-63.05K-65.98%2.06M-101.74%-87.33K332.24%1.52M-504.57%-134.85K
Net cash flow
Beginning cash position -32.59%1.61M-26.97%2.4M-26.73%1.98M44.63%2.31M-23.08%2.49M-26.97%2.4M97,988.37%3.28M14,877.56%2.7M4,274.20%1.59M442.91%3.24M
Current changes in cash 1,273.80%1.31M11.76%-780.67K-19.78%-361.81K-129.86%-329.38K88.76%-184.66K325.98%95.18K-127.00%-884.67K-109.26%-302.05K6,082.47%1.1M-193.52%-1.64M
End cash Position 17.33%2.92M-32.59%1.61M-32.59%1.61M-26.73%1.98M44.63%2.31M-23.08%2.49M-26.97%2.4M-26.97%2.4M14,877.56%2.7M4,274.20%1.59M
Free cash flow 760.73%1.36M84.78%-447.85K-34.73%-289.3K40.89%-244.31K95.20%-72.48K119.62%158.23K-6.09%-2.94M87.78%-214.72K-11.93%-413.3K-154.30%-1.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More